Urinary Incontinence Devices Companies

The urinary incontinence devices market is projected to reach USD 7.97 billion by 2030 from USD 4.22 billion in 2024, growing at a CAGR of 11.2% during the forecast period 2024-2030.

Urinary incontinence devices are clinical devices that serve to control or cure involuntary loss of urine through structural support for the bladder and urethra, control over urinary flow, or urine collection. The devices enable patients to recover bladder control, minimize the number of leakage events, and enhance quality of life. They comprise a variety of products including vaginal & urethral slings, artificial urinary sphincters, electrical stimulation devices, urinary catheters, and other supportive urinary incontinence devices like pessaries, vaginal cones, and bulking agents catering to varying types and degrees of urinary incontinence.

To know about the assumptions considered for the study download the pdf brochure

Some of the prominent players operating in the market include Coloplast Corp (Denmark), B. Braun SE (Germany), Johnson & Johnson Services, Inc. (US), Convatec Inc. (UK), Boston Scientific Corporation (US), Hollister Incorporated (US), Becton, Dickinson and Company (BD) (US), Cook Group (US), Cardinal Health (US), Laborie (US), Medtronic (Ireland), and Teleflex Incorporated (US), and among others.

Market Ranking:

The urinary incontinence devices market is led by Coloplast Corp (Denmark), B. Braun SE (Germany), and Johnson & Johnson Services, Inc. (US), based on a detailed market share analysis. This ranking was established after extensive secondary research and further validated through industry expert  insights. The ranking takes into account several important factors, such as the revenue generated from urinary incontinence devices, the variety and quality of their product offerings, and their dedication to innovation. Additionally, regulatory approvals and recent product launches have played a key role in shaping their market position. These companies continue to lead the industry due to their strong presence, wide-ranging solutions, and ongoing advancements in urinary incontinence care.

COLOPLAST CORP

As of 2023, Coloplast Corp. is the global leader in the urinary incontinence devices market. With a strong reputation in the medical equipment industry, the company has maintained its leadership through consistent investment in research and development. Coloplast places a strong emphasis on R&D across all its business segments, maintaining an annual R&D-to-sales ratio of approximately 4%. In 2023-24, the company invested USD 129.5 million (DKK 913 million) in R&D, a significant increase from previous years. Coloplast introduces new products to the market on a continuous basis, expanding its catalogue and solidifying its position as a market leader in the main medical fields.  However, the business enterprise operates in extra than 50 international locations. Expansion into rising markets is a key priority, as Coloplast seeks to capitalize on the growing healthcare needs in those regions while concurrently strengthening its presence in established markets.

B. BRAUN SE (GERMANY)

B. Braun SE: The Second Most Significant Player in the Urinary Incontinence Devices Market in 2023. B. Braun has diversified and comprehensive medical products, allowing it to serve a wide range of healthcare needs. B. Braun operates in more than 64 countries, making it one of the leading medical device manufacturers, providing excellent market penetration and servicing both developed and emerging markets. It has increased its presence in emerging markets, especially in Asia, Latin America, and the Middle East, where demand for healthcare products and services is growing quickly.

JOHNSON & JOHNSON SERVICES, INC. (US)

Johnson & Johnson Services, Inc. is recognized as the third leading player in the urinary incontinence devices market in 2023. The company has a major market presence in more than 60 countries in various regions, including North America, Europe, the Asia Pacific, and Africa. It has more than 265 operating companies and runs its businesses through its main subsidiaries. Investments at the levels that J&J makes over years guarantee a constant stream of innovation within the medical devices, pharmaceuticals, and biotechnology industries. These initiatives not only streamline its market approach but also ensure that it addresses landscape shifts in patient care with advanced technologies and innovative products.

Related Reports:

Urinary Incontinence Devices Market by Product (Urinary Catheters (Indwelling Catheters, Intermittent Catheters), Artificial Urinary Sphincters), Incontinence Type (Stress), Patient Type (Male, Female), End User (Hospitals) - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]